Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- industrial
- pharma
Sodium phosphate, dibasic, dihydrate
CAS 10028-24-7
Concern score
Not assessed — no hazard data yet.
Why it's flagged
EPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies.
Regulation
No restrictions found. Sodium phosphate, dibasic, dihydrate appears in these published regulatory listings.
- commercial_presence
- cpdat_category:industrial
- definition_level:complete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:ingredient substance
- occupational_presence
- substance_class:chemical
USFDAinactive ingredient database16 entries — 6 administration routes
- Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 55 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 3 mgSource →
- Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 55 mgSource →
- Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 52 mgSource →
- Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 12 mgSource →
- Route: NASAL; Dosage form: SPRAY, METERED; Potency: 3 mg/1mlSource →
- Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 1.2 %w/vSource →
- Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 18 mgSource →
- Route: ORAL; Dosage form: SOLUTION; Potency: 2.5 mg/1mlSource →
- Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 137 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 20 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 3 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.14 %w/vSource →
- Route: TOPICAL; Dosage form: CREAM; Potency: 0.25 %w/wSource →
- Route: TOPICAL; Dosage form: GEL; Potency: NASource →
- Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 4 mgSource →
USEPAcommercial use observedEPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies.
- EPA CPDat observed this chemical in 2 composition records across product categories including Laboratory supplies.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence
No graded sources yet for Sodium phosphate, dibasic, dihydrate. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Sodium phosphate, dibasic, dihydrate in our catalog (epa_cpdat).
Products
2
Brands
1
Laboratory supplies
See products using Sodium phosphate, dibasic, dihydrate →Found in these products
- Aloe Vera MinistarYangzhou Sion Commodity Ltd · Dentifrices
- RoséBuldak Spicy RamenCritical
- Queso blanco dipDairiesHigh
- Artisan three cheesePREGO · CondimentsHigh
- diprobaseMinor
- pure 3 triangle cakeObalab · SnacksCritical
- Jalapeno & pepper jack dipCondimentsHigh
- Beer & cheese dipDairiesCritical
- Prego sauces cheddarPrego · DairiesCritical
- Prego sauces basil pestoPrego · CondimentsHigh
- DrinkSaito InryoCritical
